Erdogan-Trinkaus Ipek bought ETON
January 12, 2026 · Form 4 insider transaction
Erdogan-Trinkaus Ipek bought 40,655 shares of Eton Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,655
Price
$0.00
Total value
N/A
InsiderErdogan-Trinkaus Ipek
Role—
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 12, 2026
Filing dateJanuary 14, 2026
Shares owned after123,878
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 12, 2030.